These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 72861)

  • 1. [Modification of the passive hemagglutination test for detection of the antibodies to capsular polysaccharide of Haemophilus influenzae type b].
    Porubinovskaia NM; Amelina IP; Monakhova SI
    Lab Delo; 1977; (8):494-6. PubMed ID: 72861
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of detection of Hemophilus influenzae type b capsular polysaccharide in infants and children with pneumonia.
    Wald ER; Levine MM
    Pediatrics; 1976 Feb; 57(2):266-8. PubMed ID: 1082573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines.
    Schneerson R; Robbins JB; Barrera O; Sutton A; Habig WB; Hardegree MC; Chaimovich J
    Prog Clin Biol Res; 1980; 47():77-94. PubMed ID: 6970933
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
    Käyhty H; Karanko V; Peltola H; Mäkelä PH
    Pediatrics; 1984 Nov; 74(5):857-65. PubMed ID: 6387614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophilus type b polysaccharide vaccine. Committee on Infectious Diseases.
    Pediatrics; 1985 Aug; 76(2):322-4. PubMed ID: 3875076
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.
    Schneerson R; Rodrigues LP; Parke JC; Robbins JB
    J Immunol; 1971 Oct; 107(4):1081-9. PubMed ID: 5315273
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
    Peltola H; Käyhty H; Sivonen A; Mäkelä H
    Pediatrics; 1977 Nov; 60(5):730-7. PubMed ID: 335348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polysaccharide vaccines against Haemophilus influenzae type B].
    Wysokińska T; Janaszek W
    Przegl Epidemiol; 1994; 48(1-2):39-44. PubMed ID: 8073141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.
    Schneerson R; Robbins JB
    N Engl J Med; 1975 May; 292(21):1093-6. PubMed ID: 48191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
    Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
    Gray BM
    Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB).
    Vella PP; Staub JM; Armstrong J; Dolan KT; Rusk CM; Szymanski S; Greer WE; Marburg S; Kniskern PJ; Schofield TL
    Pediatrics; 1990 Apr; 85(4 Pt 2):668-75. PubMed ID: 2107517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemophilus influenzae infection and their prevention by vaccination].
    Scholz H; Noack R
    Kinderarztl Prax; 1993 Aug; 61(6):189-91. PubMed ID: 8411843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive immunization for infection with Haemophilus influenzae type b.
    Santosham M; Reid R; Letson GW; Wolff MC; Siber G
    Pediatrics; 1990 Apr; 85(4 Pt 2):662-6. PubMed ID: 2179857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Background and indications for Haemophilus influenzae type b vaccines consisting of capsular antigen coupled to protein carriers.
    Anderson PW; Stein EC; Insel RA
    Contrib Microbiol Immunol; 1989; 10():115-24. PubMed ID: 2684504
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.
    Anderson P; Peter G; Johnston RB; Wetterlow LH; Smith DH
    J Clin Invest; 1972 Jan; 51(1):39-44. PubMed ID: 4536615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.
    Ahonkhai VI; Lukacs LJ; Jonas LC; Matthews H; Vella PP; Ellis RW; Staub JM; Dolan KT; Rusk CM; Calandra GB
    Pediatrics; 1990 Apr; 85(4 Pt 2):676-81. PubMed ID: 2107518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statement on Haemophilus influenzae type b polysaccharide vaccine.
    CMAJ; 1986 Jun; 134(12):1375-6. PubMed ID: 3486707
    [No Abstract]   [Full Text] [Related]  

  • 20. [Haemophilus influenzae type b infections in children].
    Neijens HJ; de Groot R; Dzoljic-Danilovic G
    Ned Tijdschr Geneeskd; 1991 Jan; 135(1):13-6. PubMed ID: 1990297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.